Lipoprotein apheresis to treat elevated lipoprotein (a)
نویسندگان
چکیده
منابع مشابه
Lipoprotein apheresis to treat elevated lipoprotein (a).
An elevated plasma concentration of lipoprotein (a) [Lp(a)] is an independent risk factor for cardiovascular disease. Life style modification and currently available drugs either fail to effectively lower plasma Lp(a) levels or do not result in clinical benefit. However, lipoprotein apheresis is very efficient in decreasing Lp(a) concentrations. A single apheresis session can acutely decrease L...
متن کاملLipoprotein Apheresis for Lipoprotein(a)-Associated Cardiovascular Disease
Received on: April 8, 2016; final version accepted on: June 24, 2016. From the Center for Nephrology, Hypertension, and Metabolic Diseases, Hannover, Germany (E.R.); 3rd Medical Clinic, University Hospital at the Technische Universität, Dresden, Germany (U.J.); Medical Health and Care Center Kempten-Allgäu, Kempten, Germany (F.H.); Dialysis and Lipid Center North Rhine, Essen, Germany (R.S.); C...
متن کاملLipoprotein-associated Phospholipase A2: Effects of Low Density Lipoprotein Apheresis
In addition to hypercholesterolemia, chronic arterial inflammation has been shown to be strongly associated with atherosclerosis and cardiovascular disease (CVD) [1]. The accumulation and oxidation of LDL within the intima trigger inflammatory processes within the vessel wall. Certain markers of inflammation, such as C-reactive protein (CRP), soluble CD40 ligand (sCD40L), oxidized LDL, and lipo...
متن کاملLipoprotein glomerulopathy treated with LDL-apheresis (Heparin-induced Extracorporeal Lipoprotein Precipitation system): a case report
INTRODUCTION Lipoprotein glomerulopathy is a glomerulonephritis which was described for the first time by Saito in 1989 and is currently acknowledged as a separate nosological entity. It is histologically characterized by a marked dilatation of the glomerular capillaries and the presence of lipoprotein thrombi in the glomerular lumens. The dyslipidemic profile is similar to that of type III dys...
متن کاملUse of CMR imaging to assess the effect of lipoprotein apheresis in patients with refractory angina and raised lipoprotein(a)
Background Angina which is refractory to conventional medical therapy and revascularisation with bypass surgery and/or percutaneous coronary intervention is extremely challenging to manage with limited treatment options and a pressing need to establish effective therapy. Lipoprotein(a) [Lp(a)], a genetically determined form of LDL-cholesterol, is an independent cardiovascular risk factor which ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Lipid Research
سال: 2016
ISSN: 0022-2275
DOI: 10.1194/jlr.r056549